Magnus Nilsson

Magnus Nilsson is founder, previously President and CEO, and since 2020 Senior Advisor at XVIVO Perfusion. He has also been President and CEO of Vitrolife and before that had various positions as Project Manager for drug development projects at Pharmacia & Upjohn, Pharmacia and Karo Bio. Magnus Nilsson is a Doctor of Medicine (Med Dr Sc) from Uppsala University and has published about twenty scientific articles.